共 50 条
RETENTION RATES OF ADALIMUMAB, ETANERCEPT AND INFLIXIMAB AS FIRST AND SECOND-LINE BIOLOGIC THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY PRACTICE: THE MAINTAIN STUDY
被引:0
|作者:
Frazier-Mironer, A.
[1
]
Cantagrel, A.
[2
]
Combe, B.
[3
]
Deschamps, V.
[4
]
Dougados, M.
[5
]
Flipo, R. -M.
[6
]
Logeart, I.
[4
]
Mariette, X.
[7
]
Schaeverbeke, T.
[8
]
Sibilia, J.
[9
]
Le Loet, X.
[10
]
机构:
[1] Univ Hosp, Paris, France
[2] Univ Hosp, Toulouse, France
[3] Univ Hosp, Montpellier, France
[4] Pfizer, Paris 14, France
[5] Univ Hosp, Cochin, Kerala, India
[6] Univ Hosp, Lille, France
[7] Univ Hosp, Le Kremlin Bicetre, France
[8] Univ Hosp, Bordeaux, France
[9] Univ Hosp, Strasbourg, France
[10] Univ Hosp, Rouen, France
关键词:
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
引用
收藏
页码:221 / 222
页数:2
相关论文